Does intravenous high-dose immunoglobulin G improve cardiac function in an adult patient with fulminant myocarditis requiring mechanical circulatory support?
High-dose intravenous immunoglobulin may serve as a potential adjunctive therapy for fulminant myocarditis by improving cardiac function and suppressing inflammatory mediators.
The cardiac function of an adult patient with fulminant myocarditis requiring a mechanical circulatory support was improved, along with the suppressed release of inflammatory mediators, after intravenous infusion with high-dose immunoglobulin. This therapy may have immunomodulatory effects and serve as a potential adjunctive therapy for patients with fulminant myocarditis.
Takeda et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: